Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma
Clinical Trials - The Bloodline with LLS
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients.
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Diffuse large B-cell lymphoma
- CAR T-cell Therapy
- Bispecific Antibodies
- Diffuse Large B-Cell Lymphoma: Effective Practices for Meaningful Care Conversations in a Changing Landscape
- You and Your Doctor: Actively Participating in Your Care: A Toolkit For Those Living With Or Caring For Someone With Diffuse Large B-Cell Lymphoma (DLBCL)
Additional LLS Support Resources:
- Information Specialists
- Free Nutrition Consultations
- Financial support
- Free telephone/web patient programs
- Free booklets
- Clinical Trial Support Center
- Young Adult Resources
- Online chats
- Support groups
- Caregiver support
- Caregiver Workbook
- Advocacy and Public Policy
- Survivorship Workbook
- LLS Community
- Mental Health Resources
Support for this episode provided by Genmab US, Inc.
The post Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma first appeared on The Bloodline with Blood Cancer United Podcast.